A Randomized, Double-blinded, Open Label Study of the Efficacy and Safety of Cefcapene Pivoxil and Amoxicillin·Clavulanate in Acute Presumed Bacterial Rhinosinusitis

OBJECTIVES: Currently established first line therapy of acute (presumed bacterial) rhinosinusitis (ARS) consists of 10 to 14 days of oral amoxicillin or cephalosporins. This study compared the clinical efficacy and tolerance of cefcapene pivoxil (CP) and amoxicillin-clavulanate (AMC) in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Eun, Han, Doo Hee, Won, Tae-Bin, Rhee, Chae-Seo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109332/
https://www.ncbi.nlm.nih.gov/pubmed/21716955
http://dx.doi.org/10.3342/ceo.2011.4.2.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109332/
https://www.ncbi.nlm.nih.gov/pubmed/21716955
http://dx.doi.org/10.3342/ceo.2011.4.2.83

Ejemplares similares